BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21656387)

  • 1. [Non-Hodgkin lymphoma of the mandible--a case report with differential diagnostic considerations].
    Heuberger BM; Weiler D; Bussmann C; Kuttenberger JJ
    Schweiz Monatsschr Zahnmed; 2011; 121(5):449-60. PubMed ID: 21656387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary diffuse large B-cell lymphoma of the mandible. A case report.
    Pié-Sánchez J; Petit J; Figueiredo R; Gay-Escoda C
    Minerva Stomatol; 2011; 60(1-2):87-92. PubMed ID: 21252853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
    Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.
    Tanaka T; Shimada K; Yamamoto K; Hirooka Y; Niwa Y; Sugiura I; Kitamura K; Kosugi H; Kinoshita T; Goto H; Nakamura S
    Ann Hematol; 2012 Mar; 91(3):383-90. PubMed ID: 21822617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary non-Hodgkin lymphoma of the mandible: apropos of three cases].
    Mahmal L; Jabri A; Jabri L; Harif M; Quessari A; Benchakroun Y; Iraqi A; Benchekroun S
    Rev Stomatol Chir Maxillofac; 2003 Apr; 104(2):111-4. PubMed ID: 12750630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary diffuse large B-Cell lymphoma of the prostate presenting with urinary retention and dyschezia for which rituximab-combined CHOP therapy was effective-a case presentation.
    Manabe M; Hayashi Y; Yoshii Y; Mukai S; Sakamoto E; Kanashima H; Nakao T; Hayama T; Fukushima H; Inoue T; Yamane T; Teshima H
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1733-5. PubMed ID: 23152030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
    Evens AM; Kanakry JA; Sehn LH; Kritharis A; Feldman T; Kroll A; Gascoyne RD; Abramson JS; Petrich AM; Hernandez-Ilizaliturri FJ; Al-Mansour Z; Adeimy C; Hemminger J; Bartlett NL; Mato A; Caimi PF; Advani RH; Klein AK; Nabhan C; Smith SM; Fabregas JC; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA
    Am J Hematol; 2015 Sep; 90(9):778-83. PubMed ID: 26044261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composite T lymphoblastic leukemia/lymphoma and diffuse large B-cell lymphoma: case report.
    Niino D; Ohsaki K; Arakawa F; Watanabe J; Kimura Y; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Sugita Y; Ohshima K; Okamura T
    Pathol Int; 2011 Jun; 61(6):363-8. PubMed ID: 21615612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary extranodal B-cell non-Hodgkin lymphoma mimicking an endodontic lesion: report of 2 cases.
    Wong GB; Spadafora S; Barbon N; Caputo M
    J Can Dent Assoc; 2013; 79():d93. PubMed ID: 24059491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma.
    Olszewski AJ; Winer ES; Castillo JJ
    Leuk Res; 2014 Aug; 38(8):866-73. PubMed ID: 24837081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
    Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
    Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.
    Yhim HY; Kim JS; Kang HJ; Kim SJ; Kim WS; Choi CW; Eom HS; Kim JA; Lee JH; Won JH; Shim H; Huh J; Lee DH; Suh C; Kwak JY
    Int J Cancer; 2012 Jul; 131(1):235-43. PubMed ID: 21823120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary diffuse large B-cell lymphoma in uterine corpus: report of a case].
    Dong W; Cao L; Wang DS
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):270-2. PubMed ID: 21616007
    [No Abstract]   [Full Text] [Related]  

  • 17. c-FLIP does not correlate with response to immunochemotherapy treatment and outcome of patients with nodal diffuse large B-cell lymphoma.
    Markovic O; Marisavljevic D; Cemerikic-Martinovic V; Filipovic B; Radovanović S; Zdravković M; Stanisavljevic D; Mihaljevic B
    Biomed Pharmacother; 2013 Jun; 67(5):445-9. PubMed ID: 23582793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma.
    Sohn BS; Kim SM; Yoon DH; Kim S; Lee DH; Kim JH; Lee SW; Huh J; Suh C
    Ann Hematol; 2012 Nov; 91(11):1731-9. PubMed ID: 22752193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical case report: a rare cause of acute kidney failure - tissue is the issue.
    Heggermont WA; Verhoef G; Evenepoel P; Sprangers B; Lerut E; Tousseyn T; Claes K
    Acta Clin Belg; 2017 Jun; 72(3):201-204. PubMed ID: 27253186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment approaches for diffuse large B-cell lymphoma].
    Miyazaki K; Yamaguchi M
    Nihon Rinsho; 2014 Mar; 72(3):483-7. PubMed ID: 24724408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.